GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Current Liabilities

ANL (Adlai Nortye) Other Current Liabilities : $0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Other Current Liabilities?

Adlai Nortye's other current liabilities for the quarter that ended in Jun. 2024 was $0.00 Mil.

Adlai Nortye's quarterly other current liabilities declined from Jun. 2023 ($336.26 Mil) to Dec. 2023 ($0.00 Mil) but then from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($0.00 Mil).

Adlai Nortye's annual other current liabilities increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($290.37 Mil) but then declined from Dec. 2022 ($290.37 Mil) to Dec. 2023 ($0.00 Mil).

Adlai Nortye Other Current Liabilities Historical Data

The historical data trend for Adlai Nortye's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Other Current Liabilities Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Other Current Liabilities
- 290.37 -

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Other Current Liabilities Get a 7-Day Free Trial 290.37 290.37 336.26 - -

Adlai Nortye Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Adlai Nortye Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Current Liabilities
Comparable Companies
ABOS IVVD CLSD MNOV AVTE ACRV NTRB EPIX IGMS DOMH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.